Correspondence 0001654954-24-014767 from Catheter Precision, Inc. (VTAK)

Catheter Precision, Inc.
Date: Nov. 21, 2024 · CIK: 0001716621 · Accession: 0001654954-24-014767

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

Nov. 21, 2024

Author

/s/ B. Joseph Alley, Jr.

Form

CORRESP

Company

Catheter Precision, Inc.

Letter

RE:

catheter_corresp.htmNovember 21, 2024

VIA EDGAR TRANSMISSION

U.S. Securities and Exchange Commission

Division of Corporate Finance

100 F Street NE

Washington, D.C. 20549

Catheter Precision, Inc.

Form S-1 Registration Statement

To Whom It May Concern:

On behalf of Catheter Precision, Inc. (the "Company"), we respectfully submit this Registration Statement on Form S-1 registering the resale of up to 10,695,962 shares of Company common stock.

Please be advised that the Company anticipates making an oral request for acceleration of effectiveness of this registration statement pursuant to Rule 461 under the Securities Act of 1933 (the "Securities Act"). In that regard, this letter confirms that the Company is aware of its obligations under the Securities Act as they relate to the offering of shares described in this registration statement.

Please call me at (404) 873-8688 if you have any questions about this filing. We would very much appreciate the staff's assistance in declaring this registration statement effective as soon as possible.

Sincerely,
/s/ B. Joseph Alley, Jr.

Show Raw Text

CORRESP
1
filename1.htm

catheter_corresp.htmNovember 21, 2024

 VIA EDGAR TRANSMISSION

 U.S. Securities and Exchange Commission

 Division of Corporate Finance

 100 F Street NE

 Washington, D.C. 20549

   RE:

   Catheter Precision, Inc.

   Form S-1 Registration Statement

 To Whom It May Concern:

 On behalf of Catheter Precision, Inc. (the "Company"), we respectfully submit this Registration Statement on Form S-1 registering the resale of up to 10,695,962 shares of Company common stock.

 Please be advised that the Company anticipates making an oral request for acceleration of effectiveness of this registration statement pursuant to Rule 461 under the Securities Act of 1933 (the "Securities Act"). In that regard, this letter confirms that the Company is aware of its obligations under the Securities Act as they relate to the offering of shares described in this registration statement.

 Please call me at (404) 873-8688 if you have any questions about this filing. We would very much appreciate the staff's assistance in declaring this registration statement effective as soon as possible.

   Sincerely,

   /s/ B. Joseph Alley, Jr.

       B. Joseph Alley, Jr.

      Copy to:

   David A. Jenkins, Executive Chair/CEO of the Company

 Margrit Thomassen, Interim CFO of the Company

SecProbe.io